Have a personal or library account? Click to login
New perspectives on the use of glucagon-like peptide 1 in diseases of the central nervous system Cover

New perspectives on the use of glucagon-like peptide 1 in diseases of the central nervous system

Current Issues in Pharmacy and Medical Sciences
Volume 36 (2023): Issue 4 (December 2023)
By: Malgorzata Lupina and  Joanna Listos  
Open Access
|Dec 2023

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/cipms-2023-0040 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Journal RSS Feed
Language: English
Page range: 232 - 235
Submitted on: Sep 22, 2023
|
Accepted on: Oct 16, 2023
|
Published on: Dec 25, 2023
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
addiction,
Parkinson disease,
Alzheimer disease,
glucagon-like peptide 1,
neuroprotective effects,
anti-inflammatory effects
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Pharmacology, toxicology,
Pharmacy,
Pharmacy, other

© 2023 Malgorzata Lupina, Joanna Listos, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 36 (2023): Issue 4 (December 2023)Next article